[
1. 1.Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007 Nov;9(6):435-40. doi: 10.1007/s11908-007-0066-4.10.1007/s11908-007-0066-4
]Search in Google Scholar
[
2. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F et al. Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395-1401. doi: https://dx.doi.org/10.3201/eid1509.090334.10.3201/eid1509.090334
]Search in Google Scholar
[
3. 3.Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012 Feb;54 Suppl 1(Suppl 1):S8-S15. doi: 10.1093/cid/cir864.10.1093/cid/cir864
]Search in Google Scholar
[
4. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1;41(5):634-53. doi: 10.1086/432579.10.1086/432579
]Search in Google Scholar
[
5. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. CurrOpin Infect Dis. 2004 Dec;17(6):517-25. doi: 10.1097/00001432-200412000-00003.10.1097/00001432-200412000-00003
]Search in Google Scholar
[
6. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019 Jan;25(1):26-34. doi: 10.1016/j.cmi.2018.07.011.10.1016/j.cmi.2018.07.011
]Search in Google Scholar
[
7. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, Simko JP, Winn BJ. Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome. Ophthalmic PlastReconstr Surg. 2021 Mar-Apr 01;37(2):e40-e80. doi: 10.1097/IOP.0000000000001889.10.1097/IOP.0000000000001889
]Search in Google Scholar
[
8. Mehta S, Pandey A. Rhino-Orbital Mucormycosis Associated With COVID-19. Cureus. 2020 Sep 30;12(9):e10726. doi: 10.7759/cureus.10726.10.7759/cureus.10726
]Search in Google Scholar
[
9. Monte Junior ESD, Santos MELD, Ribeiro IB, Luz GO, Baba ER, Hirsch BS, Funari MP, de Moura EGH. Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report. Clin Endosc. 2020 Nov;53(6):746-749. doi: 10.5946/ce.2020.180.10.5946/ce.2020.180
]Search in Google Scholar
[
10. Machouart M, Larché J, Burton K, Collomb J, Maurer P, Cintrat A, Biava MF, Greciano S, Kuijpers AF, Contet-Audonneau N, de Hoog GS, Gérard A, Fortier B. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol. 2006 Mar;44(3):805-10. doi: 10.1128/JCM.44.3.805-810.2006.10.1128/JCM.44.3.805-810.2006
]Search in Google Scholar
[
11. Ling H, Yuan Z, Shen J, Wang Z, Xu Y. Accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis. J Clin Microbiol. 2014 Jul;52(7):2573-82. doi: 10.1128/JCM.00700-14.10.1128/JCM.00700-14
]Search in Google Scholar
[
12. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15;48(12):1743-51. doi: 10.1086/599105.10.1086/599105
]Search in Google Scholar
[
13. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.10.1016/S0140-6736(20)30183-5
]Search in Google Scholar
[
14. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.10.1093/cid/ciaa530
]Search in Google Scholar
[
15. Rapp RP, McCraney SA, Goodman NL, Shaddick DJ. New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. Ann Pharmacother. 1994 Nov;28(11):1255-63. doi: 10.1177/106002809402801109.10.1177/106002809402801109
]Search in Google Scholar
[
16. Ballow CH, Amsden GW. Azithromycin: the first azalide antibiotic. Ann Pharmacother. 1992 Oct;26(10):1253-61. doi: 10.1177/106002809202601014.10.1177/106002809202601014
]Search in Google Scholar
[
17. Vossen MG, Thalhammer F. Effects of renal replacement therapy on antimicrobial therapy. Curr Clin Pharmacol. 2013 Feb 1;8(1):39-45.10.2174/1574884711308010006
]Search in Google Scholar
[
18. Syed-Ahmed M, Narayanan M. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019 Jan;26(1):8-15. doi: 10.1053/j.ackd.2019.01.004.10.1053/j.ackd.2019.01.004
]Search in Google Scholar
